Gidal BE - Search Results

1

Product labeling accuracy and contamination analysis of commercially available cannabidiol product samples.

Gidal BE, Vandrey R, Wallin C, Callan S, Sutton A, Saurer TB, Triemstra JL. Gidal BE, et al. Front Pharmacol. 2024 Mar 18;15:1335441. doi: 10.3389/fphar.2024.1335441. eCollection 2024. Front Pharmacol. 2024. PMID: 38562466 Free PMC article.

2

Lacosamide extended-release capsules are bioequivalent to lacosamide immediate-release tablets: Pharmacokinetic observations and simulations.

Wheless J, Gidal B, Gong L, Lyu S, Zheng X, Li R, Chang W, Tan M. Wheless J, et al. Epilepsy Res. 2024 May;202:107350. doi: 10.1016/j.eplepsyres.2024.107350. Epub 2024 Mar 16. Epilepsy Res. 2024. PMID: 38513537 Free article. Clinical Trial.

3

Lamotrigine use and potential for adverse cardiac effects: A retrospective evaluation in a Veteran population.

Biehl A, Taube M, Kotloski RJ, Kopacek K, Jones J, Gidal BE. Biehl A, et al. Among authors: gidal be. Epilepsy Behav. 2023 Dec;149:109496. doi: 10.1016/j.yebeh.2023.109496. Epub 2023 Nov 4. Epilepsy Behav. 2023. PMID: 37925869

4

The Tell on Telehealth.

Patel AD, Joshi C, Das R, Stern JM, Herman ST, Gidal BE. Patel AD, et al. Among authors: gidal be. Epilepsy Curr. 2024 May 30;24(4):232-241. doi: 10.1177/15357597241255274. eCollection 2024 Jul-Aug. Epilepsy Curr. 2024. PMID: 39309058 Free PMC article. Review.

5

Real-world, long-term evaluation of the tolerability and therapy retention of Epidiolex® (cannabidiol) in patients with refractory epilepsy.

Georgieva D, Langley J, Hartkopf K, Hawk L, Margolis A, Struck A, Felton E, Hsu D, Gidal BE. Georgieva D, et al. Among authors: gidal be. Epilepsy Behav. 2023 Apr;141:109159. doi: 10.1016/j.yebeh.2023.109159. Epub 2023 Mar 7. Epilepsy Behav. 2023. PMID: 36893722 Clinical Trial.

6

The Adverse Effects of Commonly Prescribed Antiseizure Medications in Adults With Newly Diagnosed Focal Epilepsy.

Barnard SN, Chen Z, Kanner AM, Holmes MG, Klein P, Abou-Khalil BW, Gidal BE, French J, Perucca P; Human Epilepsy Project. Barnard SN, et al. Among authors: gidal be. Neurology. 2024 Oct 8;103(7):e209821. doi: 10.1212/WNL.0000000000209821. Epub 2024 Sep 13. Neurology. 2024. PMID: 39270150

7

Consensus panel recommendations for the optimization of EPIDIOLEX® treatment for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex.

Wechsler RT, Burdette DE, Gidal BE, Hyslop A, McGoldrick PE, Thiele EA, Valeriano J. Wechsler RT, et al. Among authors: gidal be. Epilepsia Open. 2024 Oct;9(5):1632-1642. doi: 10.1002/epi4.12956. Epub 2024 Jul 15. Epilepsia Open. 2024. PMID: 39007525 Free PMC article. Review.

8

Zonisamide: A Comprehensive, Updated Review for the Clinician.

Gidal BE, Resnick T, Smith MC, Wheless JW. Gidal BE, et al. Neurol Clin Pract. 2024 Feb;14(1):e200210. doi: 10.1212/CPJ.0000000000200210. Epub 2023 Nov 10. Neurol Clin Pract. 2024. PMID: 38170117 Free PMC article. Review.

9

Patterns of psychotropic drug use in veterans with epilepsy: Do drug interactions matter?

Gidal BE, Rehman R, Tran T, Karasov A. Gidal BE, et al. Epilepsy Behav. 2023 Aug;145:109335. doi: 10.1016/j.yebeh.2023.109335. Epub 2023 Jul 8. Epilepsy Behav. 2023. PMID: 37429123 Free article.

10

Paxlovid^TM Information From FDA and Guidance for AES Members.

Cokley JA, Gidal BE, Keller JA, Vossler DG; Reviewed and approved by the AES Treatments Committee and Council on Clinical Activities. Cokley JA, et al. Among authors: gidal be. Epilepsy Curr. 2022 Apr 4;22(3):201-204. doi: 10.1177/15357597221088415. eCollection 2022 Jun. Epilepsy Curr. 2022. PMID: 36451851 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters